Synergy CHC is like a mini Procter & Gamble (P&G), but focused on health, beauty, and wellness products.

Think of it as a boutique version of Unilever, specializing in supplements, skincare, and lifestyle items.

• FOCUSfactor: Brain health nutritional supplements designed to support cognitive function.
• Flat Tummy: A range of lifestyle products and accessories, including teas, shakes, lollipops, supplements, apparel, and exercise accessories.
• Hand MD: Anti-aging skincare products, such as serums and creams for exfoliation, skin repair, and rehydration, along with hand soaps and hand sanitizers.

Synergy CHC Corp. (SNYR) primarily sells its consumer health care, beauty, and lifestyle products to individual consumers.

Based on its product offerings and sales channels (including television advertising campaigns and online sales), the company serves the following categories of customers:

• Health and Wellness-Conscious Individuals: This category includes consumers seeking nutritional supplements for brain health (under the FOCUSfactor brand) and general wellness, as well as individuals interested in dietary supplements and shakes for weight management or overall well-being (part of the Flat Tummy brand). These customers are typically proactive about their health and seek products to support specific health goals.
• Beauty and Skincare Enthusiasts: This segment comprises individuals who are interested in anti-aging, skin repair, and rehydration products, such as serums and creams (under the Hand MD brand). These customers often prioritize skincare routines and seek specialized products to maintain or improve their skin's appearance and health.
• Lifestyle-Oriented Consumers: This category encompasses individuals who are drawn to products that support a specific lifestyle, often related to fitness, diet, or personal well-being (under the Flat Tummy brand). This includes customers purchasing items like teas, apparel, and exercise accessories that align with a health-conscious or aspirational lifestyle.

Jack Ross, Chairman of the Board, Chief Executive Officer

Jack Ross has served as the Chief Executive Officer and Chairman of Synergy CHC since its inception in October 2014. Under his leadership, Synergy has successfully acquired eight individual brands since 2015. Described as a "lifetime business builder and entrepreneur," he possesses a proven track record across various consumer product verticals. Mr. Ross has also held leadership roles as President & Chief Executive Officer of SportsClick, Inc. (from 2009), Chief Executive Officer of Boombod Ltd. (from 2018), Chief Executive Officer & Director of Gowan Capital, Inc. (from 2011), and Chief Executive Officer of Kenek Brands, Inc. (from 2014). Additionally, he served as a Director for Pure Sports, Inc. (from 2009), Synergy Energy Strips World Wide, Inc. (from 2011), and Rio E Cig, Inc. (from 2011).

Jaime Fickett, Chief Financial Officer

Jaime Fickett was appointed Chief Financial Officer in March 2025, following a period where she served as the Senior Vice President of Finance and Operations from January 2015 to December 2024. Prior to her roles at Synergy CHC, Ms. Fickett was the Chief Financial Officer of Factor Nutrition Labs, LLC, a dietary supplements company, from August 2006 to January 2015. Her career also includes experience in the public accounting sector as an auditor from 1999 to 2006. Ms. Fickett holds a Bachelor of Science in Accounting from the University of Maine and a Master of Science in Accounting from Southern New Hampshire University.

Alfred Baumeler, President

Alfred Baumeler has served as President of Synergy CHC since January 2021. Before this, he was the Executive Vice President of Sales and Marketing for the company from August 2015 to December 2020. His experience also includes a role as Senior Vice President of Marketing for Healthy Natural Systems/Core Science Medica (CSM)/Lifeagen, a nutritional supplement company, from September 2012 to August 2015. From November 2009 to November 2011, Mr. Baumeler was the Senior Vice President and Chief Marketing Officer for Natrol, Inc., a manufacturer of vitamins, minerals, and supplements. He has held other senior positions in Sales and Marketing at companies such as Rexall Sundown, Wyeth, and Novartis. Mr. Baumeler earned a Bachelor of Science in Engineering from Rutgers University and a Master of Business Administration in Marketing and Finance from Columbia Business School.

Larry Pairo, VP of Operations & Supply Chain

Larry Pairo currently serves as the Vice President of Operations & Supply Chain for Synergy CHC Corp.

Key Business Risks for Synergy CHC (SNYR)

1. Financial Health and Going Concern Risk: Synergy CHC faces significant financial challenges, including poor financial strength, high leverage, negative shareholder equity, and an Altman Z-score in the distress zone, suggesting a potential risk of bankruptcy. The company has exhibited negative free cash flow and struggles to comfortably cover its interest obligations. Furthermore, repeated equity raises have led to shareholder dilution.
2. Concentrated Product Portfolio and Brand Dependence: The company relies heavily on a limited number of brands, such as FOCUSfactor and Flat Tummy. This concentration makes Synergy CHC vulnerable to shifts in consumer preferences or changes in retailer orders, which could significantly impact its revenue and profitability if demand for these key brands declines.
3. Intense Competition and Limited Competitive Advantage: Synergy CHC operates in a highly competitive consumer health and wellness market. The company competes with significantly larger entities possessing greater resources, established brand recognition, and wider distribution networks, which can hinder Synergy CHC's ability to maintain and expand market share and sustain profitability.

The rapid proliferation of highly targeted, digitally-native direct-to-consumer (DTC) brands in the health, beauty, and lifestyle sectors that leverage social media, influencer marketing, and subscription models. This challenges Synergy CHC's reliance on traditional retail distribution and television advertising campaigns for key brands like FOCUSfactor and Flat Tummy, as these new entrants can quickly gain market share by establishing direct relationships with consumers and adapting more rapidly to market trends.

Here are the addressable market sizes for Synergy CHC's main products:

FOCUSfactor (Brain Health Nutritional Supplements)

• United States: The U.S. brain health supplements market was valued at USD 3.56 billion in 2024 and is projected to reach USD 6.80 billion by 2030, with a compound annual growth rate (CAGR) of 11.5% from 2025 to 2030. Another estimate places the market at USD 3.63 billion in 2025, expected to reach USD 6.90 billion by 2032, growing at a CAGR of 9.6% from 2025 to 2032.
• Canada: The North America brain health supplements market, which includes Canada, is estimated to grow from US$ 2,786.2 million in 2025 to US$ 4,895.8 million by 2032, with a CAGR of 8.4% during this period.
• United Kingdom: The UK brain health supplements market generated a revenue of USD 381.7 million in 2024 and is expected to reach USD 725.8 million by 2030, with a CAGR of 11.3% from 2025 to 2030. Another report indicates the UK brain supplements market reached US$0.96 billion in 2024 and is expected to reach US$ 2.87 billion by 2032, growing with a CAGR of 14.66% during the forecast period 2025-2032.

Flat Tummy (Weight Loss Supplements)

• United States: The U.S. weight loss supplements market was valued at USD 8.5 billion in 2023. It generated a revenue of USD 8,567.2 million in 2024 and is expected to reach USD 17,973.5 million by 2030, growing at a CAGR of 13.1% from 2025 to 2030.
• Canada: The weight loss supplements market in Canada is expected to reach a projected revenue of US$ 5,025.5 million by 2030, with a CAGR of 11.9% from 2025 to 2030.
• United Kingdom: The UK weight loss supplement market is projected to reach USD 3.46 billion by 2026. The UK market for weight loss supplements is expected to grow at a CAGR of 19.7% from 2025 to 2035.

Hand MD (Anti-Aging Skincare Products)

• United States: The U.S. anti-aging products market size was estimated at USD 14.05 billion in 2024 and is projected to reach USD 27.44 billion by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The topical skincare segment held approximately a 48% share in the U.S. anti-aging market in 2024.
• Canada: The Canada anti-aging products market reached US$793.11 million in 2024 and is expected to reach US$1247.02 million by 2032, growing with a CAGR of 5.82% during the forecast period 2025-2032.
• United Kingdom: The UK anti-aging products market size was estimated at USD 3.57 billion in 2024 and is expected to reach USD 6.41 billion by 2033, growing at a CAGR of 7.1% from 2025 to 2033. The UK skincare industry as a whole is worth over $4.1 billion as of 2024.

Synergy CHC Corp. (SNYR) is anticipated to drive future revenue growth over the next two to three years through several key initiatives:

1. Expansion of the Functional Beverage Business: The company is rapidly expanding its Ready-To-Drink (RTD) functional beverage business by signing new Direct Store Distribution (DSD) networks with an aim for an all-state strategy in the near future. This expansion includes significant new distribution partnerships with major convenience store chains like EG of America (over 1,600 locations) and retailers like Wakefern Food Group (365 locations), as well as regional distributors such as AlaBev in the Southeast U.S. Synergy CHC is also increasing its sales and service personnel to accelerate the growth of its RTD business in convenience stores and has accumulated over 3 million cans of drink inventory for 2026.
2. International Market Expansion: Synergy CHC is actively pursuing international expansion for its FOCUSfactor brand and RTD beverages. The company plans to enter three new international markets, has established a subsidiary in Mexico, and has expanded its license agreement for FocusFactor to include Turkey. Additionally, new market entries in Australia and Taiwan are expected to accelerate revenue in the latter half of 2025 and beyond. Recent developments also include the expansion of FOCUSfactor functional beverage distribution across Canada through partnerships with Walmart Canada and McKesson Canada.
3. Growth of the Core FOCUSfactor Supplement Business: The flagship FOCUSfactor brain health supplement continues to be a key driver, with the brand being recognized as the number one pharmacist-recommended OTC memory supplement for 2025-2026, which reinforces its market position and brand confidence. Anticipated progress in sales, product development, and overall market expansion for the FOCUSfactor brand is expected to enhance future revenues. Analysts also recognize large market opportunities for the company's brain health supplements.
4. Strategic Distribution Partnerships in North America: The company has secured major distribution wins and expanded its network across North America. This includes a national item authorization from Core Mark, providing access to over 50,000 retail locations. Further expansion of its DSD network through new partnerships in regions like Maine and Pennsylvania is anticipated to boost sales growth for FOCUSfactor products in the Northeast market.

Share Repurchases

• Synergy CHC Corp. has made no share repurchases over the last 3-5 years, with share buybacks for SNYR stock recorded as $0.00.

Share Issuance

• In October 2024, Synergy CHC Corp. completed an Initial Public Offering (IPO) of 1,150,000 shares at $9.00 per share, resulting in net proceeds of approximately $8.4 million. These proceeds were primarily used to repay related party promissory notes and for general corporate purposes, including working capital.
• The company executed an underwritten public offering in August 2025, issuing 1,750,000 shares of common stock at $2.50 per share, which generated gross proceeds of $4.375 million for working capital and general corporate purposes. Additionally, warrants for up to 52,500 shares were granted to the underwriter.
• In 2025, stockholders approved an amendment to the 2024 Equity Incentive Plan, increasing the number of shares available for issuance and authorizing up to 1,000,000 shares of preferred stock, indicating potential future issuances.

Inbound Investments

• Synergy CHC secured a $20 million term loan credit agreement with ACP Agency, LLC in June 2025. At closing, $15 million was drawn, with an additional $2.5 million delayed draw facility and a $2.5 million uncommitted term loan incremental facility also available. These funds were primarily used to reduce existing debt and provide growth capital.
• A "$4 million equity raise" in late 2025 was noted to have fortified the company's balance sheet and positioned it for growth in 2026.

Outbound Investments

• In July 2021, Synergy CHC acquired Hand MD Corp. as a wholly-owned subsidiary.

Capital Expenditures

• Capital expenditures were reported as $0.0 for the fiscal years ending December 31, 2020, 2022, 2023, and 2024.
• However, quarterly data shows capital expenditures of $1 million for the quarter ending December 31, 2024, and $2 million for the quarter ending September 30, 2025.